|
FAM35A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.10870002067998E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.38140000549569E-08 |
| Normal-vs-Stage2 |
6.614400E-04 |
| Normal-vs-Stage3 |
5.95060000163627E-08 |
| Normal-vs-Stage4 |
1.99609999973482E-07 |
| Stage1-vs-Stage2 |
9.708800E-01 |
| Stage1-vs-Stage3 |
2.172000E-02 |
| Stage1-vs-Stage4 |
1.226960E-01 |
| Stage2-vs-Stage3 |
1.095400E-01 |
| Stage2-vs-Stage4 |
1.629350E-01 |
| Stage3-vs-Stage4 |
9.927400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.20990012347977E-10 |
| Normal-vs-AfricanAmerican |
4.15449999999762E-05 |
| Normal-vs-Asian |
1.652410E-01 |
| Caucasian-vs-AfricanAmerican |
1.435040E-01 |
| Caucasian-vs-Asian |
9.827400E-01 |
| AfricanAmerican-vs-Asian |
6.814400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.2163994518063E-10 |
| Normal-vs-Female |
4.77300000001346E-06 |
| Male-vs-Female |
3.111000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.74690003865663E-09 |
| Normal-vs-Extreme_Weight |
4.22869961269612E-10 |
| Normal-vs-Obese |
3.35980000043534E-07 |
| Normal-vs-Extreme_Obese |
4.656600E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.931800E-01 |
| Normal_Weight-vs-Obese |
1.565590E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.480560E-01 |
| Extreme_Weight-vs-Obese |
1.673400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.359760E-01 |
| Obese-vs-Extreme_Obese |
5.420400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.07169999999879E-05 |
| Normal-vs-Age(41-60Yrs) |
1.47940000028157E-07 |
| Normal-vs-Age(61-80Yrs) |
5.88510018495469E-10 |
| Normal-vs-Age(81-100Yrs) |
9.85170000022961E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.017800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.758000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.426400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.690000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.490300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.678200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.90060000004877E-06 |
| Normal-VS-Type2 PRCC |
3.57447405008315E-12 |
| Normal-VS-KIRP CIMP |
7.13480385883258E-11 |
| Normal-VS-Unclassified PRCC |
1.235440E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.83620000004936E-06 |
| Type1 PRCC-VS-KIRP CIMP |
4.36949999960135E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.932620E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.242800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.756500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.184500E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.52679996318273E-09 |
| Normal-vs-N1 |
3.82200049386938E-10 |
| Normal-vs-N2 |
1.33670000002084E-06 |
| N0-vs-N1 |
1.717620E-01 |
| N0-vs-N2 |
1.223560E-01 |
| N1-vs-N2 |
3.003200E-01 |
|
|
